# Integrative Multi-Omics Mendelian Randomization Reveals Oxidative Stress Mechanisms in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia

**Authors:** Nanxi Li, Juan Wang, Sihao Chen, Tao Li

PMC · DOI: 10.3390/antiox15020233 · Antioxidants · 2026-02-10

## TL;DR

This study uses genetic data to explore how oxidative stress might cause major psychiatric disorders like depression, bipolar disorder, and schizophrenia.

## Contribution

The study identifies specific oxidative stress-related genes with potential causal roles in psychiatric disorders using integrative multi-omics and Mendelian randomization.

## Key findings

- Genetically predicted increases in ACE and ACADVL methylation, expression, and protein abundance were linked to reduced schizophrenia risk.
- IGF1R was associated with bipolar disorder risk in blood-specific analyses.
- ENDOG expression in specific immune and brain cells was linked to higher schizophrenia risk.

## Abstract

Background: Oxidative stress (OS) has been widely implicated in pathophysiology of major psychiatric disorder. However, establishing robust causal links and delineating the specific molecular mechanisms involved continue to pose significant research challenges. Methods: We performed a multi-omics analysis focusing on 817 oxidative stress-related genes (OSGs) in major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ). We applied summary data-based Mendelian randomization (SMR), integrating large-scale genome-wide association studies for MDD, BD, and SCZ with quantitative trait loci datasets from both blood and brain tissues, including measures of DNA methylation, gene expression, and protein abundance. Results: Multi-omics integration yielded supportive evidence across blood and brain tissues implicating ACE and ACADVL in SCZ, where genetically predicted increases in their methylation, expression, and protein abundance were associated with reduced disease risk. IGF1R was associated with bipolar disorder (BD) risk in blood-specific analyses. Brain-specific analyses further nominated ENDOG as a candidate gene for SCZ. Single-cell SMR indicated that increased ENDOG expression was associated with higher SCZ risk in astrocytes, CD4+ naïve T cells, CD8+ effector T cells, and natural killer cells, suggesting a potential immune–brain interaction. Conclusions: This study provides multi-level genetic evidence supportive of a potential causal role for specific OSGs in major psychiatric disorders. We identify ACE, ACADVL, IGF1R, and ENDOG as candidate genes for further investigation, offering insights into epigenetic and transcriptional mechanisms that could inform future research on therapeutic targets.

## Linked entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636], ACADVL (acyl-CoA dehydrogenase very long chain) [NCBI Gene 37], IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480], ENDOG (endonuclease G) [NCBI Gene 2021]
- **Diseases:** major depressive disorder (MONDO:0002009), bipolar disorder (MONDO:0004985), schizophrenia (MONDO:0005090)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, STK4 (serine/threonine kinase 4) [NCBI Gene 6789] {aka KRS2, MST1, YSK3}, MDH2 (malate dehydrogenase 2) [NCBI Gene 4191] {aka DEE51, EIEE51, M-MDH, MDH, MGC:3559, MOR1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CHUK (component of inhibitor of nuclear factor kappa B kinase complex) [NCBI Gene 1147] {aka BPS2, IKBKA, IKK-1, IKK-alpha, IKK1, IKKA}, KCNK3 (potassium two pore domain channel subfamily K member 3) [NCBI Gene 3777] {aka DDSA, K2p3.1, OAT1, PPH4, TASK, TASK-1}, SELENON (selenoprotein N) [NCBI Gene 57190] {aka CFTD, CMYO3, CMYP3, MDRS1, RSMD1, RSS}, VARS2 (valyl-tRNA synthetase 2, mitochondrial) [NCBI Gene 57176] {aka COXPD20, VALRS, VARS2L, VARSL}, SLC8A1 (solute carrier family 8 member A1) [NCBI Gene 6546] {aka NCX1}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, GCH1 (GTP cyclohydrolase 1) [NCBI Gene 2643] {aka DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CREBBP (CREB binding lysine acetyltransferase) [NCBI Gene 1387] {aka CBP, KAT3A, MKHK1, RSTS, RSTS1}, FAM120A (family with sequence similarity 120 member A) [NCBI Gene 23196] {aka C9orf10, HBVPTPAP, OSSA}, LYPD4 (LY6/PLAUR domain containing 4) [NCBI Gene 147719] {aka SMR}, NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2) [NCBI Gene 4720] {aka CI-49, LHONAR2, MC1DN6}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, PRKCB (protein kinase C beta) [NCBI Gene 5579] {aka PKC-beta, PKCB, PKCI(2), PKCbeta, PRKCB1, PRKCB2}, MTRFR (mitochondrial translation release factor in rescue) [NCBI Gene 91574] {aka C12orf65, COXPD7, SPG55, mtRF-R}, GIGYF1 (GRB10 interacting GYF protein 1) [NCBI Gene 64599] {aka GYF1, PERQ1}, PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, STK24 (serine/threonine kinase 24) [NCBI Gene 8428] {aka HEL-S-95, MST3, MST3B, STE20, STK3}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, ACADVL (acyl-CoA dehydrogenase very long chain) [NCBI Gene 37] {aka ACAD6, LCACD, VLCAD}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, POR (cytochrome p450 oxidoreductase) [NCBI Gene 5447] {aka CPR, CYPOR, P450R}, CRHR1 (corticotropin releasing hormone receptor 1) [NCBI Gene 1394] {aka CRF-R, CRF-R-1, CRF-R1, CRF1, CRFR-1, CRFR1}, ENDOG (endonuclease G) [NCBI Gene 2021]
- **Diseases:** mitochondrial dysfunction (MESH:D028361), inflammatory (MESH:D007249), injury to (MESH:D014947), neuroinflammation (MESH:D000090862), SCZ (MESH:D012559), Psychiatric Disorder (MESH:D001523), OSGs (MESH:D000068099), psychiatry disorders (MESH:D009358), metabolic abnormalities (MESH:D008659), metabolic dysregulation (MESH:D021081), MDD (MESH:D003865), TRD (MESH:D061218), OS (MESH:D000079225), lipo-toxicity (MESH:D064420), BD (MESH:D001714), peroxisomal dysfunction (MESH:D018901), HEIDI (MESH:D005547), neuronal impairment (MESH:D009410), immune dysregulation (OMIM:614878)
- **Chemicals:** Omega-3 fatty acid (MESH:D015525), fatty acid (MESH:D005227), VLCFA (MESH:C017364), ROS (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938180/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938180/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938180/full.md

---
Source: https://tomesphere.com/paper/PMC12938180